Parabilis Medicines, Inc.
NASDAQ:PBLS · NASDAQ Global Market
+$0.25 today
Vol 0.67M · Avg 2.56M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Mathai Mammen | CEO, President, Treasurer & Chairman | $1.30M | — | 59 | — | — |
Teresa L. Jurgensen | Executive VP, Secretary & General Counsel | $691,586.00 | — | 48 | — | — |
Fawzi Benzaghou | Chief Medical Officer | $408,169.00 | — | 50 | — | — |
Jonathan Hurov | Executive Vice President of Discovery Biology | — | — | — | — | — |
Rohin Mhatre | Chief Technical Operations Officer | — | — | 61 | — | — |
Jianing Di | VP of International R&D and Corporate Development | — | — | — | — | — |
John McGee | Scientific Co-Founder, Executive Vice President & Head of Platform | — | — | — | — | — |
Thomas Kotarakos | Chief Financial Officer | — | — | 44 | — | — |
Marie Nguyen | Senior VP & Head of Clinical Development | — | — | — | — | — |
Kristen Stants | Chief People Officer | — | — | 53 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Peer companies in the same sector
No competitor data available.
Who manages PBLS?
Parabilis Medicines, Inc. (PBLS) lists 10 active executives. The top listed executive is Fawzi Benzaghou, Chief Medical Officer.
Explore More
Continue the stock analysis
Jump to another research area for this company.